Biomarker Research Line

During our investigation we have observed a significant increase in the levels of E2F4 phosphorylation in the serum of Alzheimer's model mice before detecting beta-amyloid peptide deposits in their brain.

This discovery has been patented as an early biomarker of Alzheimer's disease and we are now verifying its usefulness as a diagnosis in human samples.

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies